News | August 03, 2023
Supriya Lifescience collaborates with Plasma Nutrition for protein technology
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The product basket increased to 1800 medicines and 285 Surgical Equipment
Marks the World Head & Neck Cancer Day at the OCTF Conference
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
Subscribe To Our Newsletter & Stay Updated
